5' Upstream Sequences of MyD88, an IL-6 Primary Response Gene in M1 Cells: Detection of Functional IRF-1 and Stat Factors Binding Sites

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 1995 Sep 11

PMID 7567467

Citations 10

Authors

S Harroch

Y Gothelf

M Revel

J Chebath

Affiliations

Soon will be listed here.

Abstract

Transcription regulatory elements have been analyzed in upstream sequences of an Interleukin-6 (Il-6) primary response gene, MyD88. MyD88 2.3 kb mRNA is strongly and persistently induced in the course of myeloleukemic M1 cells differentiation with Il-6. MyD88 cDNA sequences were found in a region of 12 kb of mouse genomic DNA. Using Il-6 treated M1 cell RNAs, two transcription start sites have been localized, approximately 100 bp upstream from the 5' end of the cloned cDNA. We sequenced 1.4 kb of 5' genomic DNA including the first exon. In 5' of mRNA transcription start site, MyD88 nucleotidic sequence is 85% identical to 5' complementary sequences of the rat 3'-ketoacetyl CoA thiolase gene, over 1.2 kb. A DNA element conferring Il-6-inducible transcription to reporter genes, and localized 30 bp upstream of MyD88 first RNA start site, contains overlapping binding sites for cytokine activated transcription factors Stat and for the Interferon Regulatory Factor-1 and -2 (IRF-1 and IRF-2). In vitro binding assays showed that attachment of Stat factors to this element early in Il-6 treatment requires tyrosine kinase activation. IRF1, an activator of transcription, is also induced to bind to this sequence at later times. A model of persistent activation of MyD88 gene through these two types of factors is proposed.

Citing Articles

CpG hypomethylation at proximal promoter and 5'UTR along with IL6 signaling loop associates with MYD88 upregulation in epithelial ovarian cancer.

Li J, Mei B, Zhu Y, Huang J, Li M, Wang D Sci Rep. 2024; 14(1):30945.

PMID: 39730678 PMC: 11681154. DOI: 10.1038/s41598-024-81975-x.

Pyroptosis-Induced Inflammation and Tissue Damage.

Wei Y, Yang L, Pandeya A, Cui J, Zhang Y, Li Z J Mol Biol. 2021; 434(4):167301.

PMID: 34653436 PMC: 8844146. DOI: 10.1016/j.jmb.2021.167301.

Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells.

Ouk C, Roland L, Gachard N, Poulain S, Oblet C, Rizzo D Front Immunol. 2021; 12:641692.

PMID: 34017329 PMC: 8129569. DOI: 10.3389/fimmu.2021.641692.

Inflammatory Caspases Drive Pyroptosis in Acute Lung Injury.

Liu B, He R, Zhang L, Hao B, Jiang W, Wang W Front Pharmacol. 2021; 12:631256.

PMID: 33613295 PMC: 7892432. DOI: 10.3389/fphar.2021.631256.

Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.

Serezani C, Lewis C, Jancar S, Peters-Golden M J Clin Invest. 2011; 121(2):671-82.

PMID: 21206089 PMC: 3026722. DOI: 10.1172/JCI43302.

References

Ichikawa Y . Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969; 74(3):223-34. DOI: 10.1002/jcp.1040740303. View

Poli V, Mancini F, Cortese R . IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell. 1990; 63(3):643-53. DOI: 10.1016/0092-8674(90)90459-r. View

Kozak M . An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987; 15(20):8125-48. PMC: 306349. DOI: 10.1093/nar/15.20.8125. View

Benech P, Vigneron M, Peretz D, Revel M, Chebath J . Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene. Mol Cell Biol. 1987; 7(12):4498-504. PMC: 368134. DOI: 10.1128/mcb.7.12.4498-4504.1987. View

Kinoshita S, Akira S, Kishimoto T . A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci U S A. 1992; 89(4):1473-6. PMC: 48473. DOI: 10.1073/pnas.89.4.1473. View

Abdollahi A, LORD K, Liebermann D . Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 1991; 2(8):401-7. View

Hocke G, Barry D, Fey G . Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat alpha 2 macroglobulin gene. Mol Cell Biol. 1992; 12(5):2282-94. PMC: 364400. DOI: 10.1128/mcb.12.5.2282-2294.1992. View

Kishimoto T, Akira S, Taga T . IL-6 receptor and mechanism of signal transduction. Int J Immunopharmacol. 1992; 14(3):431-8. DOI: 10.1016/0192-0561(92)90173-i. View

Cohen A, Petsche D, Grunberger T, Freedman M . Interleukin 6 induces myeloid differentiation of a human biphenotypic leukemic cell line. Leuk Res. 1992; 16(8):751-60. DOI: 10.1016/0145-2126(92)90153-x. View

10.

Tanaka N, Taniguchi T . Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system. Adv Immunol. 1992; 52:263-81. DOI: 10.1016/s0065-2776(08)60877-9. View

11.

Wegenka U, Buschmann J, Lutticken C, Heinrich P, Horn F . Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol. 1993; 13(1):276-88. PMC: 358907. DOI: 10.1128/mcb.13.1.276-288.1993. View

12.

Sims S, Cha Y, Romine M, Gao P, Gottlieb K, Deisseroth A . A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol. 1993; 13(1):690-702. PMC: 358947. DOI: 10.1128/mcb.13.1.690-702.1993. View

13.

LORD K, Abdollahi A, Liebermann D . Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol. 1993; 13(2):841-51. PMC: 358967. DOI: 10.1128/mcb.13.2.841-851.1993. View

14.

Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M . Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 1993; 259(5097):971-4. DOI: 10.1126/science.8438157. View

15.

Harroch S, Gothelf Y, Watanabe N, Revel M, Chebath J . Interleukin-6 activates and regulates transcription factors of the interferon regulatory factor family in M1 cells. J Biol Chem. 1993; 268(12):9092-7. View

16.

Kollmar R, Farnham P . Site-specific initiation of transcription by RNA polymerase II. Proc Soc Exp Biol Med. 1993; 203(2):127-39. DOI: 10.3181/00379727-203-43583. View

17.

Isshiki H, Akira S, Sugita T, Nishio Y, Hashimoto S, Pawlowski T . Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: possible involvement of NF-IL6 in acute phase protein gene expression. New Biol. 1991; 3(1):63-70. View

18.

LORD K, Abdollahi A, Thomas S, DeMarco M, Brugge J, Liebermann D . Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol. 1991; 11(9):4371-9. PMC: 361299. DOI: 10.1128/mcb.11.9.4371-4379.1991. View

19.

Decker T, Lew D, Darnell Jr J . Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol Cell Biol. 1991; 11(10):5147-53. PMC: 361534. DOI: 10.1128/mcb.11.10.5147-5153.1991. View

20.

Tamaoki T . Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol. 1991; 201:340-7. DOI: 10.1016/0076-6879(91)01030-6. View